3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
5
Stomach Neoplasms
1
Sarcoma, Ewing
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Neoplasm Metastasis
1
Endometrial Neoplasms
1
Desmoid Tumors
1
Craniopharyngioma
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Anal Cancer Metastatic
1
Adenomatous Polyposis Coli
1
Interventions
Oxaliplatin
6
Capecitabine
6
Fluorouracil
5
Leucovorin
4
trastuzumab deruxtecan
3
pembrolizumab
3
cemiplimab
3
Cisplatin
3
zolbetuximab
2
fludarabine
2
durvalumab
2
Trastuzumab
2
Ramucirumab
2
Paclitaxel
2
Cyclophosphamide
2
tucatinib
1
repotrectinib
1
paricalcitol
1
lenvatinib
1
enzalutamide
1
darolutamide
1
atezolizumab
1
alpha-2'-deoxythioguanosine
1
aldesleukin
1
Vinorelbine
1
Transurethral Resection of Prostate
1
Taxes
1
Radiosurgery
1
Radiofrequency Ablation
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
trifluridine tipiracil drug combination
×
30 days
×
Clear all
No trials found.